Antineoplastic AgentsAntineoplastic Combined Chemotherapy ProtocolsRadiation InjuriesRadiation DosageRadiation, IonizingCisplatinDoxorubicinDose-Response Relationship, RadiationCombined Modality TherapyNeoplasmsRadiotherapyCell Line, TumorRadiation ToleranceEmployer Health CostsRadiotherapy DosageChemotherapy, AdjuvantDrug Resistance, NeoplasmEtoposideRadiationDrug Screening Assays, AntitumorRadiation OncologyRadiation ProtectionAntineoplastic Agents, PhytogenicRadiotherapy, ConformalRadiotherapy, Intensity-ModulatedRadiation MonitoringCell SurvivalPaclitaxelApoptosisBreast NeoplasmsRadiotherapy, AdjuvantPrescription FeesTreatment OutcomeDrug Delivery SystemsDose FractionationRadiation PneumonitisFluorouracilRadiotherapy Planning, Computer-AssistedBrachytherapyNeoplasm StagingTumor Cells, CulturedNeoplasm Recurrence, LocalRadiation-Sensitizing AgentsRadiometryNeoplasms, Radiation-InducedDisease-Free SurvivalBrain NeoplasmsRadiation Injuries, ExperimentalSurvival AnalysisDose-Response Relationship, DrugRadiosurgeryGamma RaysCyclophosphamideCell ProliferationCranial IrradiationSurvival RateOvarian NeoplasmsLung NeoplasmsCosmic RadiationPrognosisHead and Neck NeoplasmsRadiotherapy, Computer-AssistedTime FactorsNeoadjuvant TherapyGene Expression Regulation, NeoplasticAdenocarcinomaParticle AcceleratorsRadiotherapy, Image-GuidedCarcinoma, Squamous CellRadiation-Protective AgentsFollow-Up StudiesRadiotherapy, High-EnergyRadiodermatitisAntibiotics, AntineoplasticBackground RadiationChemoradiotherapyVinblastineDrug Administration ScheduleBleomycinCarboplatinDNA DamageProstatic NeoplasmsAntineoplastic Agents, AlkylatingOrgans at RiskAntimetabolites, AntineoplasticUltraviolet RaysCarcinoma, Non-Small-Cell LungDacarbazineTomography, X-Ray ComputedMethotrexateXenograft Model Antitumor AssaysMice, NudeCobalt RadioisotopesTumor BurdenRadiation EffectsHodgkin DiseaseCamptothecinClinical Trials as TopicRetrospective StudiesOrganoplatinum Compounds